Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Mallinckrodt
McKesson
Baxter
Medtronic

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR HALOBETASOL PROPIONATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Halobetasol Propionate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00715975 ↗ Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis Completed Azidus Brasil Phase 2/Phase 3 2008-07-01 The Psoriasis and a chronic dermatosis characterized by abnormal proliferation of cells epithelial, vessel dilation and inflammation locally, which presents erythematous-scaly lesions in various areas of the body, preferably in the scalp, region and religious joints as elbows and knees. It occurs equally in both sexes and can appear at any age, and the mean age for the onset of the disease and around 27.3 years. The halobetasol propionate and an ultra-potent corticoid. Its chemical structure and similar to the Clobetasol corticoid this, until then classified as the most potent corticoid used worldwide in clinical practice. However, the molecular structure of Halobetasol gives it increased its activity antiinflammatory and anti-proliferative. The objective of this study is evaluating the efficacy and tolerability of the drug Halobetasol propionate cream formulation as a treatment in patients with plaque psoriasis mild to moderate, compared to the substance of similar power, Clobetasol propionate - Psorex - Cream.
NCT00802958 ↗ Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments Completed Padagis LLC 2003-07-01 The purpose of this study was to compare the relative vasoconstrictive effects of test and reference Halobetasol Propionate 0.05% Ointment in healthy, female subjects.
NCT00802958 ↗ Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments Completed Perrigo Company 2003-07-01 The purpose of this study was to compare the relative vasoconstrictive effects of test and reference Halobetasol Propionate 0.05% Ointment in healthy, female subjects.
NCT00803166 ↗ Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams Completed Padagis LLC 2004-01-01 The purpose of this study was to compare the relative vasoconstrictive effects of two test and one reference Halobetasol Propionate 0.05% Cream in healthy, female subjects.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Halobetasol Propionate

Condition Name

Condition Name for Halobetasol Propionate
Intervention Trials
Plaque Psoriasis 9
Healthy 4
Psoriasis 4
Atopic Dermatitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Halobetasol Propionate
Intervention Trials
Psoriasis 13
Eczema 1
Dermatitis, Atopic 1
Dermatitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Halobetasol Propionate

Trials by Country

Trials by Country for Halobetasol Propionate
Location Trials
United States 65
Brazil 1
Georgia 1
Panama 1
Ukraine 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Halobetasol Propionate
Location Trials
California 10
Florida 7
Texas 5
Pennsylvania 3
Michigan 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Halobetasol Propionate

Clinical Trial Phase

Clinical Trial Phase for Halobetasol Propionate
Clinical Trial Phase Trials
Phase 4 7
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Halobetasol Propionate
Clinical Trial Phase Trials
Completed 12
Recruiting 3
Terminated 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Halobetasol Propionate

Sponsor Name

Sponsor Name for Halobetasol Propionate
Sponsor Trials
Bausch Health Americas, Inc. 4
Sun Pharmaceutical Industries Limited 3
Therapeutics, Inc. 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Halobetasol Propionate
Sponsor Trials
Industry 24
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Boehringer Ingelheim
Merck
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.